[1] |
Misgar RA,Mubarik I,Wani AI,et al. Emphysematous pyelonephritis: a 10-year experience with 26 cases[J]. Indian J Endocrinol Metab,2016,20(4): 475-480.
|
[2] |
Ranjan SK,Navriya SC,Kumar S,et al. Emphysematous cystitis:a case report and literature review of 113 cases[J]. Urol Ann,2021,13(3): 312-315.
|
[3] |
李艳秀,曹权. 脓毒症血管活性药物的选择[J]. 江苏大学学报(医学版),2023,33(2): 107-111.Li YX,Cao Q. Selection of vasoactive drugs for sepsis[J]. J Jiangsu Univ Med Ed,2023,33(2): 107-111.
|
[4] |
Desai R,Batura D. A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis[J].Int Urol Nephrol,2022,54(4): 717-736.
|
[5] |
Nikitha N,Satpathy PK. Study of infections in type 2 diabetes mellitus[J]. J Assoc Physicians India,2022,70(4): 11-12.
|
[6] |
Kapoor R,Muruganandham K,Gulia AK,et al. Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis[J]. BJU Int,2010,105(7): 986-989.
|
[7] |
Newcomer JB,Myers CB,Chacon E,et al. Percutaneous drainage for non-operative management of emphysematous pyelonephritis:clinical characteristics and predictors of success[J]. J Clin Imaging Sci,2022,15: 59.
|
[8] |
Singh U,Sankhwar SN,Kumar M. Emphysematous pyelonephritis with scrotal extension: an unusual case presentation[J]. Cureus,2023,15(9): e45065.
|
[9] |
Huang JJ,Tseng CC. Emphysematous pyelonephritis:clinicoradiological classification,management,prognosis,and pathogenesis[J]. Arch Intern Med,2000,160(6): 797-805.
|
[10] |
Koch GE,Johnsen NV. The diagnosis and management of lifethreatening urologic infections[J]. Urology,2021,156: 6-15.
|
[11] |
Chaudhari P,Sawant R,Bordoloi M,et al. Non-albicans candida infection as a rare cause of emphysematous pyelonephritis in an uncontrolled diabetic patient: a case report[J]. Cureus,2024,16(3):e57036.
|
[12] |
Villasuso-Alcocer V,Flores-Tapia JP,Perez-Garfias F,et al. Serratia fonticola and its role as a single pathogen causing emphysematous pyelonephritis in a non-diabetic patient: a case report[J]. World J Clin Cases,2022,10(29): 10600-10605.
|
[13] |
Ideguchi S,Yamamoto K,Ikeda A,et al. A case of bilateral emphysematous pyelonephritis caused by Candida albicans[J]. J Infect Chemother,2019,25(4): 302-306.
|
[14] |
Batirel A,Regmi SK,Singh P,et al. Urological infections in the developing world: an increasing problem in developed countries[J].World J Urol,2020,38(11): 2681-2691.
|
[15] |
Wu SY,Yang SS,Chang SJ,et al. Emphysematous pyelonephritis:classification,management,and prognosis[J]. Tzu Chi Med J,2022,34(3): 297-302.
|
[16] |
Bhat SK,Srivastava A,Ansari NA,et al. Emphysematous pyelonephritis in type 2 diabetes - clinical profile and management[J].Saudi J Kidney Dis Transpl,2021,32(6): 1646-1654.
|
[17] |
Li S,Wang J,Hu J,et al. Emphysematous pyelonephritis and cystitis:a case report and literature review[J]. J Int Med Res,2018,46(7):2954-2960.
|
[18] |
Huang JJ,Tseng CC. Emphysematous pyelonephritis:clinicoradiological classification,management,prognosis,and pathogenesis[J]. Arch Intern Med,2000,160(6): 797-805.
|
[19] |
Lu YC,Chiang BJ,Pong YH,et al. Emphysematous pyelonephritis:clinical characteristics and prognostic factors[J]. Int J Urol,2014,21(3): 277-282.
|
[20] |
Gite VA,Shaw V,Agrawal M,et al. Minimally invasive techniques as a first line approach in the management of emphysematous pyelonephritis - a single centre experience[J]. J Postgrad Med,2021,67(3): 146-153.
|
[21] |
Misgar RA,Mubarik I,Wani AI,et al. Emphysematous pyelonephritis: a 10-year experience with 26 cases[J]. Indian J Endocrinol Metab,2016,20(4): 475-480.
|
[22] |
Hinkamp CA,Keshvani N. Emphasising classification in emphysematous pyelonephritis[J]. Lancet,2020,395(10230): 1145.
|
[23] |
Kone K,Mallikarjun NT,Rams MDRKK. Mortality in emphysematous pyelonephritis: can we reduce it further by using a protocol-based treatment? The results of a prospective study[J]. Urol Ann,2022,14(1): 73-80.
|
[24] |
安恒庆,陈兴发,姜华,等. 上尿路疾病经皮穿刺途径诊疗安全共识[J]. 现代泌尿外科杂志,2021,26(2): 107-111.An HQ,Chen XF,Jiang H,et al. Safety consensus on diagnosis and treatment of upper urinary tract diseases by percutaneous puncture[J].J Mod Urol,2021,26(2): 107-111.
|
[25] |
Somani BK,Nabi G,Thorpe P,et al. Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review[J]. J Urol,2008,179(5): 1844-1849.
|